WHITE BEAR LAKE, Minn., Oct. 18, 2016 -- Pathway Health (www.pathwayhealth.com) announces they have entered into an exclusive licensing agreement with Florida Atlantic University (FAU) (www.fau.edu) to provide INTERACT® training, education, management, consulting services, including INTERACT™ 4.0 for Skilled Nursing Facilities, INTERACT™ 1.0 for Assisted Living and INTERACT™ 1.0 for Home Health. Under the terms of the agreement Pathway Health will also be sub-licensing the copyrighted INTERACT™ 4.0 and INTERACT™ 1.0 systems to entities such as Electronic Health Record providers and other technologies that want to incorporate INTERACT into their product offerings.
“Our nearly 20 years as a proven resource to the health care field, coupled with our insight, expertise and knowledge in the post-acute care continuum were the reasons that FAU selected Pathway Health as the exclusive company with the right to license and provide training, education and expertise to providers implementing INTERACT,” said Pathway Health Chief Executive Officer Peter B. Schuna.
INTERACT® (Interventions to Reduce Acute Care Transfers) is a quality improvement program that focuses on the management of acute change in patient condition. It includes clinical and educational tools, strategies to implement them, and related educational resources.
“Even though the INTERACT quality improvement program is publicly available, effective implementation and ongoing training are key to substantially reduce unnecessary interventions, as well as complications and costs associated with these interventions,” said FAU Vice President for Research Daniel C. Flynn, Ph.D.
Through this agreement, Pathway Health will continue to leverage their expansive network of consultants and strategic partners to help reduce hospital readmission rates and improve overall efficiencies.
“Pathway Health’s expert consultants will collaboratively assist hospitals, skilled nursing and assisted living facilities, home care companies and accountable care organizations improve the quality of care by providing key insights and training to support providers’ value-based care initiatives,” commented INTERACT creator Joseph G. Ouslander, M.D.
To learn more about how to effectively implement INTERACT or becoming a strategic partner, contact Peter Schuna at 877-777-5463.
About Pathway Health
Pathway Health is a professional management, consulting, interim management, executive search and education services organization, serving clients across the post-acute care continuum. Since 1997, Pathway Health has been keeping a pulse on industry clinical, regulatory, quality and reimbursement trends to keep clients on the path to success. With over 150 experienced professionals, we engage and employ leading clinical and operational experts to assist our clients in achieving the next level of performance.
For more information, call 877-777-5463 or visit www.pathwayhealth.com.
About INTERACT®
INTERACT® (Interventions to Reduce Acute Care Transfers) is a quality improvement program that has been adopted throughout the United States, and is also being used in other countries, including Canada, the United Kingdom, and Singapore. INTERACT® was first designed in a project supported by the Centers for Medicare and Medicaid Services (CMS). Many post-acute providers across the country are using INTERACT® Program materials. The current versions of the INTERACT® were developed by an interdisciplinary team under the leadership of Dr. Joseph G. Ouslander, M.D. with input from many direct care providers and national experts in projects based at Florida Atlantic University. For more information, visit http://interact.fau.edu
Media Contact for Pathway Health: Mopdog, Inc. Cheryl Musial Chief Strategy Officer [email protected] 678-737-7325


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



